Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 07 - 20 entities : Pfizer, inc. save search
BIOGEN INC. AGREES TO PAY $900 MILLION TO RESOLVE WHISTLEBLOWER CLAIM REGARDING PAYMENT OF UNLAWFUL KICKBACKS
Published: 2022-07-20 (Crawled : 20:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.04%
H: 0.14%
C: -1.11%
BIIB | $193.18 -0.48% -0.48% 1.4M
|
Health Technology
|
| O: -1.48%
H: 1.71%
C: -4.38%
resolve payment
Oligomerix Announces Key Organizational Changes in Transition to Clinically Focused Company
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.04%
H: 0.14%
C: -1.11%
IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market Players Observe High Demand for TNF Inhibitors, Notes TMR Report
Published: 2022-07-20 (Crawled : 12:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: -4.54%
H: 3.88%
C: 3.88%
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
PFE | News 4 | $26.32 0.23% 0.0% 24M
|
Health Technology
|
| O: 0.04%
H: 0.14%
C: -1.11%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.81%
H: 0.05%
C: -1.27%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -2.23%
H: 0.0%
C: 0.0%
treatment report market ulcerative colitis
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.